LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring

By LabMedica International staff writers
Posted on 17 Mar 2025
Image: Carbon nanotubes with different chirality or “twist” have different optical properties (Photo courtesy of Mikael Nyberg/University of Turku)
Image: Carbon nanotubes with different chirality or “twist” have different optical properties (Photo courtesy of Mikael Nyberg/University of Turku)

Current sensors can measure various health indicators, such as blood glucose levels, in the body. However, there is a need to develop more accurate and sensitive sensor materials that can detect lower concentrations of certain substances. For instance, female hormones are present in the body at concentrations millions of times lower than glucose. To effectively study hormone fluctuations, highly sensitive sensors are required, and this necessitates a significant improvement in the accuracy of biosensors. In a new study, researchers have developed nanomaterials that could contribute to more accurate sensors for future healthcare applications. These advancements could lead to continuous health monitoring, enabled by carbon nanotubes.

Researchers at the University of Turku (Turku, Finland) have successfully created sensors using single-wall carbon nanotubes, which are well-suited for such applications. Single-wall carbon nanotubes are made from a single atomic layer of graphene. Until now, a major challenge in developing these materials has been that the nanotube manufacturing process yields a mix of conductive and semi-conductive nanotubes, which vary in chirality—the way the graphene sheet is rolled into the cylindrical shape of the nanotube. The electrical and chemical properties of nanotubes are highly dependent on their chirality. The research team developed methods to separate nanotubes with different chiralities, and in this study, they successfully distinguished between two nanotubes with similar chiralities while identifying their typical electrochemical properties.

By purifying and separating the carbon nanotubes, the researchers were able to test their differences as sensor materials. Although nanotubes are typically used in hybrid sensors when combined with other surfactants, the current study focused on sensors made entirely from nanotubes. Furthermore, the researchers gained precise control over the concentration of nanotubes, allowing them to compare the properties of different chiralities. One key finding was that one type of nanotube (6.5) was more efficient than the other (6.6) in adsorbing dopamine. Adsorption, which refers to the ability of a material to bind atoms or molecules to its surface, is especially crucial when the concentrations of the substances being measured are very low. The study's results are the first to demonstrate that the electrochemical response of the sensor is influenced by chirality. In future research, computational models could be employed to determine the optimal chirality for measuring each molecule.

“The result is significant because by being able to precisely control the properties of carbon nanotubes we can fine-tune the ability of the sensor material to detect changes in specific substances," said Doctoral Researcher Ju-Yeon Seo.

Related Links:
University of Turku

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
ESR Analyzer
TEST1 2.0

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more